Lufotrelvir
Lufotrelvir (PF-07304814) is a 3CL protease inhibitor targeting SARS-CoV-2, designed for COVID-19 research. It exhibits broad-spectrum activity against related coronaviruses in vitro and has demonstrated antiviral efficacy in animal models, supporting its investigation for novel coronavirus infections.
Product Specifications
CAS Number
2468015-78-1
Product Name Alternative
PF-07304814, SARS-CoV-2 3CL, SARSCoV
Field of Research
Infectious Disease & Virology
Purity
99.43% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (7.24 mM) ; H2O:30 mg/mL (54.3 mM) ; DMSO:100 mg/mL (180.99 mM)
Smiles
O (C) C1=C2C (NC (C (N[C@H] (C (N[C@@H] (C[C@H]3C (=O) NCC3) C (COP (=O) (O) O) =O) =O) CC (C) C) =O) =C2) =CC=C1
Molecular Formula
C24H33N4O9P
Molecular Weight
552.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1139906 1.0 µg DNA
KIAA1305 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details MBS1350736-01 0.02 mg (E-Coli)
Recombinant Pyrococcus abyssi Uncharacterized protein PYRAB13970 (PYRAB13970)
Sign In for Pricing
View Details